First patient treated in global strategic collaboration involving Cydar Maps technology

Cydar Maps

Cydar Medical has announced the successful treatment of the first patient in a strategic collaboration with Medtronic. The collaboration, which spans 40 sites across the U.S., UK and Europe, involves the integration of the company’s Cydar Maps software with Medtronic’s services and case support, with the aim of improving patient care and the efficiency of medical professionals by introducing unique artificial intelligence (AI) solutions into the clinical environment.

The first patient in the pilot program was treated using Cydar Maps at Edward Hospital  in Naperville, Illinois, by vascular and endovascular surgeon George Pontikis, MD.

Cydar Maps is the first product from Cydar’s AI technology platform and, according to the company, transforms the way information is provided to clinicians undertaking image-guided minimally invasive surgery (MIS) simplifying complexities within operating theaters at leading hospitals across the globe.

The company explains that Cydar Maps generates a 3D map of patient soft tissue to support and integrate preoperative planning, intraoperative guidance and postoperative review of endovascular MIS, using AI to update the map throughout the patient journey. Cydar Maps has been shown to offer a number of benefits, a company press release reports, including halving the radiation exposure for patients and the clinical team, simplifying the clinical workflow and increasing clinician confidence, which in turn can significantly reduce procedure times.

The pilot program is also expected to inform the ongoing development of Cydar Maps, which will include predictive analytics to support optimized procedure planning based on the use of AI to compare patient anatomy and procedure outcomes from a global data set.

Pontikis said: “This cutting-edge technology empowers us with the ability to navigate complex vascular procedures with greater precision—ensuring optimal outcomes for our patients. We are honored to be a part of this innovative program and are eager to contribute to the advancement of endovascular aortic surgery.”


Please enter your comment!
Please enter your name here